John Womelsdorf, CEO

AIMM therapeutics B.V. was established in 2004 with the goal to develop therapeutic and...

Andrew Smith, CFO

A private clinical stage biopharmaceutical company, established in 2013 and is dedicated to the...

Eric Converse, CEO

AMRA Medical is a ground-breaking, international digital health company at the forefront of...

Gregory Gorgas, CEO

Artelo Biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline...

Barnaby Balmforth, CEO

Biofidelity has developed a revolutionary molecular diagnostic assay, enabling the rapid...

Andres McAllister, CMO

BioInvent’s strategy is to leverage its expertise in antibodies and cancer biology to develop...

Robert de Jonge, CEO

Targeting stress response pathways in cancer

Jean-Luc Vandebroek, CFO

Bone Therapeutics is a leading cell therapy company addressing high unmet medical needs in...

Chaim Lebovits, CEO

Brainstorm Cell Therapeutics is developing innovative, autologous stem cell therapies for highly...

David Mazzo, President & CEO

Caladrius Biosciences, Inc. is a clinical stage development company with cell therapy...

Derk Arts, Founder & CEO

Castor is a cloud-based data solution, enabling researchers to easily capture and integrate...

Michael Hawthorne, CEO

Using our human iPSC derived cells from healthy and specific disease populations we can custom...

Peter De Keizer, CEO & Founder

Serghei Glinca, CEO

Ineke Rijnhout, CEO

DC4U is a life science company developing technologies that enable steering the human immune...

Neil Clark, CEO

Destiny Pharma plc is a clinical stage, biotechnology company focused on the development of novel...

Goran Beijer, CEO

Dicot's most important product is Libiguin™ for the treatment of erectile dysfunction and premature...

Mark Emalfarb, CEO

Dmitry Pshezhetskiy, Director

Guido Maertens, CEO

Enzyre B.V. is developing a handheld, battery powered, diagnostic platform for near patient...

Frederik Lehmann, CEO

EpiEndo Pharmaceuticals is a privately held Icelandic pharmaceutical company developing a...

Tim Brears, CEO

We are a spin-out company that is currently incubating in the centre of the world-renowned Cambridge...

Vincent Fert, CEO

The complexity of the immune response to tumors calls for intensifying and combining academic and...

 Vladislav Sandler, CEO

Hemogenyx Pharmaceuticals plc ("Hemogenyx") is a publicly traded company (LSE: HEMO)...

Max Ostermeier, CEO

Implandata Ophthalmic Products GmbH is a digital health company, based in Hannover Germany. With...

Giulio Cerroni, CEO

IXICO’s TrialTracker® platform and Artificial Intelligence (AI) software algorithms are used by...

Carlos de Sousa, CEO

Mary Kerr, CEO

KaNDy Therapeutics is developing NT-814 a unique once daily dual mechanism neurokinin-1,3 antagonist,...

Oren Glanz, CEO

Lempo Therapeutics is a pre-clinical biotech company, pioneering a paradigm shift in the modification...

Cameron Frayling, CEO

Our mission is to push the boundaries of complex cell analysis. Using the Lightcast platform we...

Nicholas Staples, CEO

Locate Bio is a privately owned UK biotechnology company developing advanced medicines using...

Søren Bregenholt, CEO

Macrophage Pharma is developing a highly novel class of small molecule therapeutics which...

Adrian Kinkaid, CEO

Charles Garvey, CEO

Metabolomic Diagnostics Ltd., is collaborating with University College Cork, Ireland, (UCC) and...

Raymond Spencer, CFO

MGB Biopharma’s focus is to further develop their completely new class of anti-infective...

Barry Sharples, Chairman

Focused for 7 years, harnessing ground breaking science, with disruptive potential…

Nicolas Vergauwe, CEO

miDiagnostics aims to bring clinical, blood-based diagnostics to the people who need it the...

Natalia Perekhvatova, CEO

Mitotech S.A. is a Luxembourg-based clinical stage biotechnology company developing novel...

Henry Appelbaum, CEO

Novian Health is a privately held medical device company based in Chicago with a subsidiary in...

Han van ‘t Klooster, CEO

PharmaCytics’ Technology serves the increasing need for drug delivery technologies. Our...

Alan Knox, Group CEO

Primex Pharmaceuticals is a leading global innovative anaesthesia company, expanding in...

Joe Dupere, CEO

Rexgenero is a leading regenerative medicine company and developer of advanced cell-based...

Cliff Holloway, CEO

Cancer remains one of the world’s most significant diseases. A key challenge in the fight against...

Marc Ramis Castelltort, CEO

Senolytic Therapeutics (STX) is a biotech company developing novel medicines by targeting...

Carl Sterritt, Founder & CEO

Shield is a de-risked commercial stage, pharmaceutical company with a focus on...

Lily Bouzelmat, Director of Operations

SolasCure’s mission is to support healthcare professionals with wound care...

Jessica Martinsson, CEO

Sprint Bioscience is a pharmaceutical company focused on developing drugs for cancer. We also...

Visa Sippola, CEO & Co-Founder

Surgify technology enables surgeons to reduce patient suffering by protecting the...

Aino Kalervo, CBO

TILT Biotherapeutics, founded in 2013, is developing a breakthrough treatment for cancer using...

Thomas Farb, CEO

Thrive Bioscience, based in Boston, is automating and providing data and analytics to a neglected...

Lars Kober, CEO

UGA Biopharma’s core area of business is the contract development of biologics and biosimilars. This...

Michael Stein, CEO

Miguel Forte, CEO

Zelluna Immunotherapy AS is a privately owned biopharmaceutical company founded in 2016 focused on...

Sameer Kothari, CEO

Zilico Ltd is developing the next generation of diagnostic devices and surgical tools which...